Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DSM and Roche Vitamins

This article was originally published in The Tan Sheet

Executive Summary

FTC clears $1.89 bil. sale of Roche Vitamins & Fine Chemicals Unit to Dutch firm DSM under terms of proposed consent agreement announced Sept. 23. Agreement calls for combined firm to divest its phytase enzyme business for swine and poultry food to BASF. Public comments are being accepted until Oct. 22, after which FTC will vote to finalize agreement. DSM, Roche must wait for European Commission approval of the merger as well. Deal was first announced in September 2002 (1"The Tan Sheet" Sept. 9, 2002, p. 6)...

You may also be interested in...



DSM To Acquire Leading Position In Vitamin Supply Market With Roche Deal

Dutch life sciences and performance materials producer DSM will enter the vitamin and carotenoid supply business at the top with the planned acquisition of Roche's Vitamins and Fine Chemicals division

US FDA Needs Plan For Addressing Inspection Backlog Post-COVID, GAO Says

Agency must plan to ensure that a growing backlog of surveillance inspections does not impede its ability to conduct inspections at high-risk sites, GAO official says.

Health And Wellness Trademark Review 2 March, 2021

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Topics

UsernamePublicRestriction

Register

OM007466

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel